We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

House Committee Seeks Answers From FDA About Anticoagulant Adverse Events

(September 15, 2015, 2:19 PM EDT) -- WASHINGTON, D.C. — Two members of the House Energy and Commerce Committee on Sept. 2 asked the Food and Drug Administration what steps, if any, the agency is taking to address...
To view the full article, register now.